Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the ...

"Boehringer Ingelheim has a forward-looking approach to unifying its technology and data landscape to rapidly deliver therapies that improve human and animal health," said Tom Schwenger, president and ...

Boehringer Ingelheim has been awarded a multi-year contract to continue to provide antigen and vaccine supply capability as ...

Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes: Ingelheim, Germany Wednesday, November 13, 2024, 10:00 Hrs [IST] Boehringer Ingelheim and the ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...

STORY German pharmaceutical company sees great benefits from CIIE spillover effectSHOOTING TIME Recent footageDATELINE Nov 10 2024LENGTH 00011 ...

U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers ...

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure ...